Pieris Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)1holders −40
0new positions
19sold out
$0.17avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Pieris Pharmaceuticals Inc. in their 13F filings, down 40 from Q1 2024. 0 opened new positions and 19 sold out. The largest holder was Orange Investment Advisors, Inc. ($2K).
- Company
- Pieris Pharmaceuticals Inc.
- CUSIP
- 720795103
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 19 | $877K |
All 13F filers, Q1 2024 → Q2 2024: 2,988,503 shares sold, net −2,988,503 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Orange Investment Advisors, Inc. | 0.00% | No change | 14,000 | $2K |
"% of holder's portfolio" is PIERIS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Pieris Pharmaceuticals Inc. the manager owns.